相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Heat Shock Protein-90 Inhibition Alters Activation of Pancreatic Stellate Cells and Enhances the Efficacy of PD-1 Blockade in Pancreatic Cancer
Yuchen Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2021)
Immune checkpoint inhibition in syngeneic mouse cancer models by a silicasome nanocarrier delivering a GSK3 inhibitor
Sean D. Allen et al.
BIOMATERIALS (2021)
Reshaping the Immune Microenvironment by Oncolytic Herpes Simplex Virus in Murine Pancreatic Ductal Adenocarcinoma
Liming Zhang et al.
MOLECULAR THERAPY (2021)
Treatment landscape of metastatic pancreatic cancer
Sara De Dosso et al.
CANCER TREATMENT REVIEWS (2021)
Experimental Evolution Generates Novel Oncolytic Vesicular Stomatitis Viruses with Improved Replication in Virus-Resistant Pancreatic Cancer Cells
Sara L. Seegers et al.
JOURNAL OF VIROLOGY (2020)
Regulatory T-cell Depletion Alters the Tumor Microenvironment and Accelerates Pancreatic Carcinogenesis
Yaqing Zhang et al.
CANCER DISCOVERY (2020)
Combination of PD-1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic Cancer
Ying Ma et al.
GASTROENTEROLOGY (2020)
Myeloid Cell-Derived Arginase in Cancer Immune Response
Tomasz M. Grzywa et al.
FRONTIERS IN IMMUNOLOGY (2020)
Oncolytic virotherapy for pancreatic ductal adenocarcinoma: A glimmer of hope after years of disappointment?
Evelyne Tassone et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
A DNA Hypomethylating Drug Alters the Tumor Microenvironment and Improves the Effectiveness of Immune Checkpoint Inhibitors in a Mouse Model of Pancreatic Cancer
Tamas A. Gonda et al.
CANCER RESEARCH (2020)
Mirage or long-awaited oasis: reinvigorating T-cell responses in pancreatic cancer
Michael Brandon Ware et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy
Christianne Groeneveldt et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Neutrophils as Orchestrators in Tumor Development and Metastasis Formation
Lydia Kalafati et al.
FRONTIERS IN ONCOLOGY (2020)
Pancreatic Fibroblast Heterogeneity: From Development to Cancer
Paloma E. Garcia et al.
CELLS (2020)
Tumor-Derived Myeloid Cell Chemoattractants and T Cell Exclusion in Pancreatic Cancer
Robert H. Vonderheide et al.
FRONTIERS IN IMMUNOLOGY (2020)
Current status of treatment with immune checkpoint inhibitors for gastrointestinal, hepatobiliary, and pancreatic cancers
Yuji Eso et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2020)
A new oncolytic Vaccinia virus augments antitumor immune responses to prevent tumor recurrence and metastasis after surgery (vol 8, e000415, 2020)
Jahangir Ahmed et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Overexpression of Smac by an Armed Vesicular Stomatitis Virus Overcomes Tumor Resistance
Weike Li et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
TGF- Inhibitors in Metastatic Pancreatic Ductal Adenocarcinoma
Marcus A. Alvarez et al.
JOURNAL OF GASTROINTESTINAL CANCER (2019)
Immune therapies in pancreatic ductal adenocarcinoma: Where are we now?
Marc Hilmi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
A Phase II Study of Pelareorep (REOLYSIN®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma
Devalingam Mahalingam et al.
CANCERS (2018)
Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression
Yu Zhu et al.
IMMUNITY (2017)
Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis
Takahiro Tsujikawa et al.
CELL REPORTS (2017)
Pancreatic ductal adenocarcinoma: State-of-the-art 2017 and new therapeutic strategies
Marta Chiaravalli et al.
CANCER TREATMENT REVIEWS (2017)
A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol
Jacek Hajda et al.
BMC CANCER (2017)
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
Antoni Ribas et al.
CELL (2017)
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
Andrew J. Aguirre et al.
CANCER CELL (2017)
Recombinant oncolytic poliovirus, PVSRIPO, has potent cytotoxic and innate inflammatory effects, mediating therapy in human breast and prostate cancer xenograft models
Eda K. Holl et al.
ONCOTARGET (2016)
Exclusion of T Cells From Pancreatic Carcinomas in Mice Is Regulated by Ly6Clow F4/80+ Extratumoral Macrophages
Gregory L. Beatty et al.
GASTROENTEROLOGY (2015)
Anti-IL-6 and PD-L1 antibody combination therapy reduces tumor progression in murine models of pancreatic cancer
Thomas Mace et al.
Journal for ImmunoTherapy of Cancer (2015)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Experimental Evolution of an Oncolytic Vesicular Stomatitis Virus with Increased Selectivity for p53-Deficient Cells
Raquel Garijo et al.
PLOS ONE (2014)
Pancreatic Cancer-Associated Stellate Cells Promote Differentiation of Myeloid-Derived Suppressor Cells in a STAT3-Dependent Manner
Thomas A. Mace et al.
CANCER RESEARCH (2013)
Targeting CXCL12 from FAP-expressing carcinomaassociated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
Christine Feig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus
Danit Finkelshtein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Attenuated, Oncolytic, but Not Wild-Type Measles Virus Infection Has Pleiotropic Effects on Human Neutrophil Function
Yu Zhang et al.
JOURNAL OF IMMUNOLOGY (2012)
Virotherapy induces massive infiltration of neutrophils in a subset of tumors defined by a strong endogenous interferon response activity
X. Fu et al.
CANCER GENE THERAPY (2011)
Safety Studies on Intrahepatic or Intratumoral Injection of Oncolytic Vesicular Stomatitis Virus Expressing Interferon-β in Rodents and Nonhuman Primates
Nathan Jenks et al.
HUMAN GENE THERAPY (2010)
Genomic Evolution of Vesicular Stomatitis Virus Strains with Differences in Adaptability
Isabel S. Novella et al.
JOURNAL OF VIROLOGY (2010)
分享论文
